Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Description

This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.

Conditions

End of Life, Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Condition
End of Life
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama at Birmingham, Birmingham, Alabama, United States, 35294

Mobile

University of South Alabama, Mobile, Alabama, United States, 36688

Duarte

Beckman Research Institute of City of Hope, Duarte, California, United States, 91010

Fresno

VA Medical Center, Fresno, Fresno, California, United States, 93703

Fruitdale

Santa Clara Valley Medical Center, Fruitdale, California, United States, 95128

Fullerton

St Jude Heritage Medical Group, Fullerton, California, United States, 92835

Los Angeles

Oncology Institute for Hope and Innovation, Los Angeles, California, United States, 90017

Mather

Sacramento VA Medical Center - VA Northern California Health Care System, Mather, California, United States, 95655

Monterey

Pacific Cancer Care, Monterey, California, United States, 93940

Palo Alto

VA Palo Alto, Palo Alto, California, United States, 94305

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Newly diagnosed patients with solid tumor cancer diagnosis or recurrence of the disease.
  • 2. Patients must have the ability to understand and willingness to provide verbal consent.
  • 3. Participants must speak English, Spanish, Chinese, or Vietnamese.
  • 1. Inability to consent to the study
  • 2. Plans to change oncologist within 12 months
  • 3. Employed by the practice site
  • 4. Patients who anticipate moving from the area within 12 months

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Study Record Dates

2028-02-28